P170013S004

None

FDA Premarket Approval P170013 S004

This post-approval study has not been publically released by the fda. It may be a place-holder supplement number.

Pre-market Approval Supplement Details

DeviceP170013S004
Classification NameNone
Applicant
PMAP170013
SupplementS004

Supplemental Filings

Supplement NumberDateSupplement Type
P170013Original Filing
S009 2022-06-10 Normal 180 Day Track No User Fee
S008
S007 2021-09-08 Normal 180 Day Track No User Fee
S006 2021-04-23 Real-time Process
S005
S004
S003 2020-11-24 Normal 180 Day Track No User Fee
S002 2018-09-06 Special (immediate Track)
S001

© 2022 FDA.report
This site is not affiliated with or endorsed by the FDA.